Helix BioPharma Cash from Financing (TTM) Analysis

Helix BioPharma Corp (HBPCF)

0.1377 0.00 (0.00%) USD | OTCM | Apr 17, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
October 31, 2023	2.349M
July 31, 2023	2.300M
April 30, 2023	4.038M
January 31, 2023	6.437M
October 31, 2022	6.815M
July 31, 2022	4.887M
April 30, 2022	4.795M
January 31, 2022	2.437M
October 31, 2021	5.196M
July 31, 2021	5.150M
April 30, 2021	3.618M
January 31, 2021	6.686M
October 31, 2020	5.602M
July 31, 2020	9.739M
April 30, 2020	9.228M
January 31, 2020	7.507M
October 31, 2019	7.219M
July 31, 2019	4.088M
April 30, 2019	4.969M
January 31, 2019	3.937M
October 31, 2018	2.982M
July 31, 2018	5.575M
April 30, 2018	6.298M
January 31, 2018	7.151M
October 31, 2017	7.841M

Date	Value
July 31, 2017	5.073M
April 30, 2017	4.315M
January 31, 2017	6.166M
October 31, 2016	5.121M
July 31, 2016	4.347M
April 30, 2016	3.485M
January 31, 2016	7.026M
October 31, 2015	7.008M
July 31, 2015	6.996M
April 30, 2015	11.89M
January 31, 2015	5.154M
October 31, 2014	9.468M
July 31, 2014	9.468M
April 30, 2014	4.225M
January 31, 2014	4.372M
October 31, 2013	0.00
July 31, 2013	0.00
April 30, 2013	-0.0006M
January 31, 2013	0.0005M
October 31, 2012	-0.0003M
July 31, 2012	0.0426M
April 30, 2012	-0.2521M
January 31, 2012	6.148M
October 31, 2011	6.394M
July 31, 2011	15.52M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

2.300M

Minimum

Jul 2023

9.739M

Maximum

Jul 2020

5.424M

Average

5.150M

Median

Jul 2021

Cash from Financing (TTM) Benchmarks